SCHEMBL10037153

SCHEMBL10037153

Cc1ccc(S(=O)(=O)NC(c2ccccc2)C(C)C)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
NPSR1 Q6W5P4 4/20 0.60
CA2 P00918 6/20 0.54
CA1 P00915 4/20 0.54
CA9 Q16790 3/20 0.54
CA7 P43166 3/20 0.54
MMP9 P14780 3/20 0.54
MMP1 P03956 2/20 0.54
MMP2 P08253 2/20 0.54
MMP3 P08254 2/20 0.54
MMP7 P09237 2/20 0.54
MMP13 P45452 2/20 0.54
CA12 O43570 2/20 0.53
HTT P42858 2/20 0.52
TSHR P16473 1/20 0.51
LMNA P02545 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50
KDM4E B2RXH2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2068561 0.93 ALDH1A1 (0.59) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL607797 0.93 ALDH1A1 (0.59) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL2067591 0.93 ALDH1A1 (0.59) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL2068549 0.93 ALDH1A1 (0.59) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL26307859 0.90 ALDH1A1 (0.57) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL16687761 0.89 ALDH1A1 (0.56) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL15167127 0.88 ALDH1A1 (0.55) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL15841450 0.87 ALDH1A1 (0.54) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL2242382 0.87 ALDH1A1 (0.54) ALDH1A1NPSR1CA2CA1CA9
SCHEMBL2242392 0.87 ALDH1A1 (0.54) ALDH1A1NPSR1CA2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077711-A1 Novel Ligands and Libraries of Ligands SUNESIS PHARMACEUTICALS, INC. (US) 2012-03-29 US disclosed
US-20120077711-A1 Novel Ligands and Libraries of Ligands SUNESIS PHARMACEUTICALS, INC. (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077711-A1 Novel Ligands and Libraries of Ligands LSS, ABCG2, SELL ALDH1A1 533/4885NPSR1 4/4885CA2 4793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.